Clinical Trial: Topical Ruxolitinib Evaluation in Chronic Hand Eczema
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hand Eczema
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).
Read more